Effect of lowering tumour necrosis factor-α on vascular endothelial function in Type II diabetes

Clinical Science

Volumn 103, Issue 2, 2002, Pages 163-169

  Bilsborough, William ^a   O'Driscoll, Gerard ^a   Stanton, Kim ^a   Weerasooriya, Rukshen ^a   Dembo, Lawrence ^a   Taylor, Roger ^a   Green, Daniel ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acetylcholine; Blood flow; Diabetes; Endothelium; High resolution ultrasound; Nitric oxide; Pentoxifylline; Plethysmography; Tumour necrosis factor

Indexed keywords

ACETYLCHOLINE; GLYCERYL TRINITRATE; N(G) METHYLARGININE; NITROPRUSSIDE SODIUM; PENTOXIFYLLINE; PLACEBO; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM;

EID: 0036343196     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs1030163     Document Type: Article

References (48)

1. Atherosclerosis: An inflammatory disease
2. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
3. Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: Pilot study to assess the predictive value in comparison with angina pectoris, exercise electrophysiology and myocardial perfusion imaging
4. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction
5. Late prognostic value of flow-mediated dilatation in the brachial artery of patients with chest pain
6. Diabetes and cardiovascular disease: A statement for the healthcare professionals from the American Heart Association
7. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo
8. Dyslipoproteinaemia and hyperoxidative stress in the pathogenesis of endothelial dysfunction in non-insulin dependent diabetes mellitus: An hypothesis
9. Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus
10. Improvement in endothelial function by ACE inhibition in non-insulin-dependent diabetes mellitus
11. The effect of combined aerobic and resistance exercise training on vascular function in type 2 diabetes
12. Losartan, an angiotensin type I receptor antagonist, improves conduit vessel endothelial function in Type II diabetes
13. Cellular and molecular mechanisms of endothelial cell dysfunction
14. Hypercholesterolemia increases endothelial superoxide anion production
15. - imbalance in insulin-resistant rat aorta
16. Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia
17. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilatlon of brachial artery
18. Free radical production in endothelial cells as a pathogenetic factor for vascular dysfunction in the insulin resistance state
19. HDL, its enzymes and its potential to influence lipid peroxidation
20. Adverse endothelial function and the insulin resistance syndrome
21. Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes
22. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium
23. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells
24. Tumour necrosis factor α activates a p22phox-based NADH oxidase in vascular smooth muscle
25. Administration of tumour necrosis factor-α in vivo depresses endothelium-dependent relaxation
26. Serum levels of tumour necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus
27. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus
28. Circulating tumor necrosis factor-α concentrations in a native Canadian population with high rates of type 2 diabetes mellitus
29. Inhibition of the biological activity of tumour necrosis factor maintains vascular endothelial cell function during hyperdynamic sepsis
30. Pentoxifylline suppression of tumour necrosis factor gene transcription
31. The HMG-CoA reductase inhibitor, simvastatin, improves endothelial function within one month
32. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo
33. Improved analysis of brachial artery ultrasound images using a novel edge-detection software system
34. Measuring forearm blood flow and interpreting the responses to drugs and mediators
35. Shock- and ischemia-induced mechanisms of impairment of endothelium-mediated vasodilation
36. Mechanism of the beneficial effects of pentoxifylline on hepatocellular function following trauma-hemorrhage and rescuscitation
37. Nitric oxide. To block or enhance its production during sepsis?
38. Pentoxifylline attenuates the depressed endothelial cell function and vascular muscle contractility following trauma and hemorrhagic shock
39. Tumour necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumour necrosis factor α in vitro and in vivo
40. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
41. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function
42. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: Central role of tumour necrosis factor-α
43. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
44. Inhibition of insulin receptor signaling by TNF: Potential role in obesity and non-insulin-dependent diabetes mellitus
45. Plasma levels of tumor necrosis factor-α (TNF-α) are essentially dependent on visceral fat amount in type 2 diabetic patients
46. Endothelium-dependent vasodilation is augmented by angiotensin-converting enzyme inhibitors in healthy volunteers
47. Changes in flow-mediated brachial artery vasoactivity with lowering of desirable cholesterol levels in healthy middle-aged men
48. Excercise training enhances endothelial function in young men